Abbott to purchase St. Jude Medical in $25 billion deal

Julian Emanuel, U.S. equity and derivatives strategist at UBS, and Gary Shilling, president at A. Gary Shilling & Co., discuss Abbott Laboratories' agreement to buy St, Jude Medical Inc.